Exploring the Connection Between Osteoporosis Induced by Medications and Gut Microbiota Alterations
By
Monika Martiniakova
Anna Sarocka
Noemi Penzes
Vladimira Mondockova
Aneta Sevcikova
Sona Ciernikova
Veronika Kovacova
Roman Biro
Joanna Folwarczna
Radoslav Omelka
June 1, 2026
Clinical Scorecard: Exploring the Connection Between Osteoporosis Induced by Medications and Gut Microbiota Alterations
At a Glance
Category Detail
Condition
Key Mechanisms Alterations in gut microbiota affecting bone health through immune modulation and nutrient absorption.
Target Population
Care Setting
Key Highlights
Drug-induced osteoporosis is a significant global health concern affecting over 200 million individuals. The gut microbiota plays a role in regulating bone homeostasis.
Guideline-Based Recommendations
Diagnosis
Identify secondary causes of osteoporosis, including medication use.
Management
Consider pharmacological interventions and lifestyle modifications.
Monitoring & Follow-up
Preventive monitoring of bone mineral density (BMD) is essential.
Risks
Chronic use of certain medications can lead to reduced BMD.
Patient & Prescribing Data
Patients using medications associated with secondary osteoporosis.
Therapeutic approaches include pharmacological interventions and lifestyle changes.
Clinical Best Practices
Regular assessment of bone health in patients on long-term medication. Encourage adequate intake of calcium and vitamin D.
Related Resources & Content